Early and out-of-hospital use of COVID-19 convalescent plasma: An international assessment of utilization and feasibility.

ABSTRACT:

Background and objectives

The use of coronavirus disease 2019 (COVID-19) convalescent plasma (CCP) in the treatment of patients with severe acute respiratory syndrome-2 infection has been controversial. Early administration of CCP before hospital admission offers a potential advantage. This manuscript summarizes current trials of early use of CCP and explores the feasibility of this approach in different countries.

Materials and methods

A questionnaire was distributed to the International Society of Blood Transfusion (ISBT) CCP working group. We recorded respondents' input on existing trials on early/outpatient CCP and out-of-hospital (OOH)/home transfusion (HT) practices in their countries and feedback on challenges in initiating home CCP infusion programmes. In addition, d

SUBMITTER: Al-Riyami AZ 

PROVIDER: S-EPMC9538090 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature